Recuvyra

RSS

Expired

This medicine's authorisation has expired

fentanyl
MedicineVeterinaryExpired

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Recuvyra has expired following the marketing-authorisation holder’s decision not to apply for a renewal.

български (BG) (568.84 KB - PDF)

Rodyti

español (ES) (537.02 KB - PDF)

Rodyti

čeština (CS) (573.8 KB - PDF)

Rodyti

dansk (DA) (511.6 KB - PDF)

Rodyti

Deutsch (DE) (515.35 KB - PDF)

Rodyti

eesti (ET) (539.37 KB - PDF)

Rodyti

ελληνικά (EL) (586.2 KB - PDF)

Rodyti

français (FR) (538.28 KB - PDF)

Rodyti

italiano (IT) (535.2 KB - PDF)

Rodyti

latviešu (LV) (569.81 KB - PDF)

Rodyti

lietuvių (LT) (534.12 KB - PDF)

Rodyti

magyar (HU) (548.34 KB - PDF)

Rodyti

Malti (MT) (576.33 KB - PDF)

Rodyti

Nederlands (NL) (513.44 KB - PDF)

Rodyti

polski (PL) (552.75 KB - PDF)

Rodyti

português (PT) (535.52 KB - PDF)

Rodyti

română (RO) (533.59 KB - PDF)

Rodyti

slovenčina (SK) (570.05 KB - PDF)

Rodyti

slovenščina (SL) (564.24 KB - PDF)

Rodyti

suomi (FI) (533.75 KB - PDF)

Rodyti

svenska (SV) (535.74 KB - PDF)

Rodyti

Product information

български (BG) (1.46 MB - PDF)

Rodyti

español (ES) (876.92 KB - PDF)

Rodyti

čeština (CS) (1.18 MB - PDF)

Rodyti

dansk (DA) (873.6 KB - PDF)

Rodyti

Deutsch (DE) (889.37 KB - PDF)

Rodyti

eesti (ET) (830.81 KB - PDF)

Rodyti

ελληνικά (EL) (1.51 MB - PDF)

Rodyti

français (FR) (864.23 KB - PDF)

Rodyti

hrvatski (HR) (875.28 KB - PDF)

Rodyti

italiano (IT) (859.62 KB - PDF)

Rodyti

latviešu (LV) (1.25 MB - PDF)

Rodyti

lietuvių (LT) (810.52 KB - PDF)

Rodyti

magyar (HU) (1.25 MB - PDF)

Rodyti

Malti (MT) (1.26 MB - PDF)

Rodyti

Nederlands (NL) (855.45 KB - PDF)

Rodyti

polski (PL) (1.23 MB - PDF)

Rodyti

português (PT) (838.3 KB - PDF)

Rodyti

română (RO) (1 MB - PDF)

Rodyti

slovenčina (SK) (1.18 MB - PDF)

Rodyti

slovenščina (SL) (1.13 MB - PDF)

Rodyti

suomi (FI) (858.03 KB - PDF)

Rodyti

svenska (SV) (851.7 KB - PDF)

Rodyti

Íslenska (IS) (879.42 KB - PDF)

Rodyti

norsk (NO) (836.37 KB - PDF)

Rodyti
Latest procedure affecting product information:IB/0009/G
13/10/2016

български (BG) (498.29 KB - PDF)

Rodyti

español (ES) (458.29 KB - PDF)

Rodyti

čeština (CS) (487.32 KB - PDF)

Rodyti

dansk (DA) (460.34 KB - PDF)

Rodyti

Deutsch (DE) (460.75 KB - PDF)

Rodyti

eesti (ET) (460.29 KB - PDF)

Rodyti

ελληνικά (EL) (495.78 KB - PDF)

Rodyti

français (FR) (460.31 KB - PDF)

Rodyti

hrvatski (HR) (471.53 KB - PDF)

Rodyti

italiano (IT) (460.57 KB - PDF)

Rodyti

latviešu (LV) (491.15 KB - PDF)

Rodyti

lietuvių (LT) (475.45 KB - PDF)

Rodyti

magyar (HU) (485.61 KB - PDF)

Rodyti

Malti (MT) (488.27 KB - PDF)

Rodyti

Nederlands (NL) (458.26 KB - PDF)

Rodyti

polski (PL) (485.72 KB - PDF)

Rodyti

português (PT) (460.24 KB - PDF)

Rodyti

română (RO) (474.03 KB - PDF)

Rodyti

slovenčina (SK) (487.71 KB - PDF)

Rodyti

slovenščina (SL) (477.71 KB - PDF)

Rodyti

suomi (FI) (458.28 KB - PDF)

Rodyti

svenska (SV) (460.23 KB - PDF)

Rodyti

Íslenska (IS) (457.47 KB - PDF)

Rodyti

norsk (NO) (461.18 KB - PDF)

Rodyti

Product details

Name of medicine
Recuvyra
Active substance
fentanyl
International non-proprietary name (INN) or common name
fentanyl
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QN02AB03

Pharmacotherapeutic group

Nervous system

Therapeutic indication

For the control of pain associated with orthopaedic and soft tissue surgery in dogs.

Authorisation details

EMA product number
EMEA/V/C/002239
Marketing authorisation holder
Eli Lilly and Company Limited 

Eli Lilly and Company Limited
Lilly House
Priestley Road
Basingstoke
Hampshire RG24 9NL
United Kingdom

Marketing authorisation issued
06/10/2011
Expiry of marketing authorisation
13/10/2016
Revision
4

Assessment history

This page was last updated on

Share this page